Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
📈 JP Morgan upgraded Akamai Technologies from an Underweight rating to Neutral on Thursday, August 13, 2026.
💰 The analyst firm increased its price target for Akamai shares from $132 to $158 following the rating upgrade.
📊 This move reflects a revised outlook for Akamai within the context of broader market stability and inflation data release.
Bullish Signals
- JP Morgan upgraded Akamai Technologies from Underweight to Neutral, indicating an improved investment view on the company's prospects.
- The analyst firm raised its price target for Akamai shares from $132 to $158, suggesting a higher valuation expectation.
Full Analysis
Akamai Technologies (NASDAQ: AKAM) is the subject of an analyst rating change reported by JP Morgan on Thursday, August 13, 2026. The firm upgraded its rating for Akamai from Underweight to Neutral, signaling a shift in its investment stance regarding the company's prospects. This adjustment comes amidst a broader market context where inflation data remained inline with expectations, leading to modest gains across major indices like the Nasdaq and S&P 500.
